Literature DB >> 8523585

Sequence variability of Borna disease virus open reading frame II found in human peripheral blood mononuclear cells.

M Kishi1, Y Arimura, K Ikuta, Y Shoya, P K Lai, M Kakinuma.   

Abstract

A cDNA fragment of the Borna disease virus (BDV) open reading frame II (ORF-II), which encodes a 24-kDa phosphoprotein (p24 [P protein]), was amplified from total RNA of peripheral blood mononuclear cells (PBMC) from three psychiatric inpatients. The amplified cDNA fragments were cloned, sequenced, and analyzed. A total of 15 clones, 5 from each patient, were studied. Intrapatient divergencies of the BDV ORF-II nucleotide sequence were 4.2 to 7.3%, 4.8 to 7.3%, and 2.8 to 7.1% for the three patients, leading to differences of 7.7 to 14.5%, 10.3 to 17.1%, and 6.0 to 16.2%, respectively, in the deduced amino acid sequence for BDV p24. Interpatient divergencies among the 15 clones were 5.9 to 12.7% at the nucleotide level and 12.8 to 28.2% at the amino acid level. Thus, in p24, BDV in human PBMC of the patients undergoes mutation at high rates in vivo. Additionally, we found that the nucleotide sequence of the 15 human BDV ORF-II cDNA clones differed from those of the horse strains V and He/80-1 by 4.2 to 9.3%. However, comparison of the consensus amino acid sequence deduced from the 15 human clones with those of the horse strains revealed no human-specific amino acid residue, suggesting that the BDV infecting humans may be related to that infecting horses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8523585      PMCID: PMC189858     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Borna disease virus, a negative-strand RNA virus, transcribes in the nucleus of infected cells.

Authors:  T Briese; J C de la Torre; A Lewis; H Ludwig; W I Lipkin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

Review 2.  Gene expression of vesicular stomatitis virus genome RNA.

Authors:  A K Banerjee; S Barik
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

3.  Molecular characterization of the Borna disease agent.

Authors:  J C de la Torre; K M Carbone; W I Lipkin
Journal:  Virology       Date:  1990-12       Impact factor: 3.616

4.  Human infections with Borna disease virus: seroprevalence in patients with chronic diseases and healthy individuals.

Authors:  L Bode; S Riegel; W Lange; H Ludwig
Journal:  J Med Virol       Date:  1992-04       Impact factor: 2.327

5.  Antigenic relationship and further characterization of two major Borna disease virus-specific proteins.

Authors:  N Thiedemann; P Presek; R Rott; L Stitz
Journal:  J Gen Virol       Date:  1992-05       Impact factor: 3.891

6.  A borna virus cDNA encoding a protein recognized by antibodies in humans with behavioral diseases.

Authors:  S VandeWoude; J A Richt; M C Zink; R Rott; O Narayan; J E Clements
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

Review 7.  Borna disease, a possible hazard for man?

Authors:  R Rott; S Herzog; K Bechter; K Frese
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

Review 8.  Infection with Borna disease virus: molecular and immunobiological characterization of the agent.

Authors:  J A Richt; S VandeWoude; M C Zink; J E Clements; S Herzog; L Stitz; R Rott; O Narayan
Journal:  Clin Infect Dis       Date:  1992-06       Impact factor: 9.079

9.  Borna disease virus in peripheral blood mononuclear and bone marrow cells of neonatally and chronically infected rats.

Authors:  A M Sierra-Honigmann; S A Rubin; M G Estafanous; R H Yolken; K M Carbone
Journal:  J Neuroimmunol       Date:  1993-06       Impact factor: 3.478

10.  Detection of Borna disease virus-reactive antibodies from patients with affective disorders by western immunoblot technique.

Authors:  Z F Fu; J D Amsterdam; M Kao; V Shankar; H Koprowski; B Dietzschold
Journal:  J Affect Disord       Date:  1993-01       Impact factor: 4.839

View more
  20 in total

Review 1.  Borna disease virus and human disease.

Authors:  K M Carbone
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

2.  Characterization of the Borna disease virus phosphoprotein, p23.

Authors:  S Kliche; L Stitz; H Mangalam; L Shi; T Binz; H Niemann; T Briese; W I Lipkin
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  Genetic relationship of Borna disease virus isolates.

Authors:  Oliver Planz; Hanns-Joachim Rziha; Lothar Stitz
Journal:  Virus Genes       Date:  2003-01       Impact factor: 2.332

4.  High-dose Borna disease virus infection induces a nucleoprotein-specific cytotoxic T-lymphocyte response and prevention of immunopathology.

Authors:  E Furrer; T Bilzer; L Stitz; O Planz
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells.

Authors:  O Planz; S Pleschka; S Ludwig
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  High prevalence of Borna disease virus infection in healthy sheep in Japan.

Authors:  K Hagiwara; S Kawamoto; H Takahashi; Y Nakamura; T Nakaya; T Hiramune; C Ishihara; K Ikuta
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

7.  Detection of Borna disease virus (BDV) antibodies and BDV RNA in psychiatric patients: evidence for high sequence conservation of human blood-derived BDV RNA.

Authors:  C Sauder; A Müller; B Cubitt; J Mayer; J Steinmetz; W Trabert; B Ziegler; K Wanke; N Mueller-Lantzsch; J C de la Torre; F A Grässer
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 8.  Borna disease virus.

Authors:  Mady Hornig; Thomas Briese; W Ian Lipkin
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

9.  Fine structure and morphogenesis of Borna disease virus.

Authors:  T Kohno; T Goto; T Takasaki; C Morita; T Nakaya; K Ikuta; I Kurane; K Sano; M Nakai
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  RNA from Borna disease virus in patients with schizophrenia, schizoaffective patients, and in their biological relatives.

Authors:  Sandra Odebrechet Vargas Nunes; Eiko Nakagawa Itano; Marla Karine Amarante; Edna Maria Vissoci Reiche; Helen Cristina Miranda; Carlos Eduardo Coral de Oliveira; Tiemi Matsuo; Heber Odebrechet Vargas; Maria Angelica Ehara Watanabe
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.